RETRACTED: Silencing lncRNAs PVT1 Upregulates miR-145 and Confers Inhibitory Effects on Viability, Invasion, and Migration in EC
Open Access
- 5 December 2019
- journal article
- retracted article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 19, 668-682
- https://doi.org/10.1016/j.omtn.2019.11.030
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Long non‐coding RNA urothelial cancer‐associated 1 promotes bladder cancer cell migration and invasion by way of the hsa‐miR‐145–ZEB1/2–FSCN1 pathwayCancer Science, 2015
- Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinomaOncotarget, 2015
- MicroRNA-145 inhibits lung cancer cell metastasisMolecular Medicine Reports, 2014
- The role of microRNA-133b and its target gene FSCN1 in gastric cancer.Journal of Experimental & Clinical Cancer Research, 2014
- DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic CancerPLOS ONE, 2013
- MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer ProgressionCancer Research, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- 1-p-Chlorophenyl-4,4-dimethyl-5-diethylamino-1-penten-3-one hydrobromide, a sulfhydryl-specific compound which reacts irreversibly with protein thiols but reversibly with small molecular weight thiolsAnalytical Biochemistry, 1989